Acute transverse myelitis following SARS-CoV-2 infection during treatment for ulcerative colitis with anti-TNFα therapy.

Publication date: Mar 19, 2025

We report a case of acute transverse myelitis (ATM) following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a 59-year-old man. This patient had been treated for ulcerative colitis (UC) for 4. 5 years with several medications, including a tumor necrosis factor (TNF)-α inhibitor. Because this patient developed ATM almost concurrently with the onset of coronavirus disease 2019, SARS-CoV-2 infection was considered the likely cause of ATM, although TNF-α inhibitor therapy and the autoimmune condition UC might also have played a role.

Concepts Keywords
Colitis Acute transverse myelitis
Coronavirus COVID-19
Neurosurg Ulcerative colitis
Old

Semantics

Type Source Name
disease MESH Acute transverse myelitis
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH ulcerative colitis
disease MESH infection
disease IDO role

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *